We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AbbVie Biotechnology Limited v. The Mathilda and Terence Kennedy Institute of Rheumatology Trust

Track this case

Case overview

Case Number:

1:11-cv-02541

Court:

New York Southern

Nature of Suit:

Patent

Judge:

Paul A. Crotty

Firms

Companies

Sectors & Industries:

  1. June 26, 2013

    AbbVie Gets Humira Patent Invalidated As Obvious

    AbbVie Inc. has won a ruling in New York federal court declaring invalid a patent for the anti-inflammatory drug Humira held by the Mathilda and Terence Kennedy Institute of Rheumatology Trust, meaning the drugmaker no longer will have to pay the trust licensing fees.

  2. October 14, 2011

    Trust Can't Boot Abbott's Humira Patent Challenge

    A New York federal judge on Friday shot down a move by the Mathilda and Terence Kennedy Institute of Rheumatology Trust to dismiss Abbott Biotechnology Ltd.'s suit over the institute's patent allegedly covering the anti-inflammatory drug Humira.